Protocol Ledger

NCT07567040 · Phase III · RECRUITING

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

Interventional Phase III clinical trial protocol NCT07567040 sponsored by Ohio State University in Ophthalmology and Sensory, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-05-27 Enrollment: 664 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07567040
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)664 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07567040
Protocol FieldVerified Registry Value
NCT IdentifierNCT07567040
Consolidated Lead SponsorOhio State University
Therapeutic Condition CohortOphthalmology and Sensory
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment664 participants (ESTIMATED)
Registered Start Date2026-05-27
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07567040
Hospital Research SiteLocationSite Profile
Stanford Health Care and Stanford Cancer InstituteStanford, CAOpen Hospital Dossier ->
Ohio State University Comprehensive Cancer CenterColumbus, OHOpen Hospital Dossier ->

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Ohio State University Wexner Medical Center across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI